Skip to content
Meta-flux logo — Meta-flux is an AI biologist for pharmaceutical drug develop...

Meta-flux

Meta-flux is an AI biologist for pharmaceutical drug development.

Founded 2021 Ireland Ireland 7 employees Seed Total: $1.80M AI, Biotechnology +1

General Information

Company Name Meta-flux
Founded Year 2021
Location Ireland Ireland
Employees 7
Industries AI, Biotechnology, Health Care
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Meta-flux. To contact Meta-flux, visit meta-flux.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Meta-flux compare?

A PDF of Meta-flux and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Meta-flux soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 03, 2026

Meta-flux will be attending BIO-Europe in Cologne from November 9 to 11.

About Meta-flux

Meta-flux, founded in 2021, is an innovative player in the intersection of AI, Biotechnology, and Health Care, with its headquarters in Ireland. The company's slogan, "Meta-flux is an AI biologist for pharmaceutical drug development," succinctly captures its mission to revolutionize the pharmaceutical industry through cutting-edge technology.

Meta-flux's platform leverages AI and multi-omic data to facilitate adaptive experimentation, positioning itself as a pivotal tool in drug development. Their approach significantly accelerates the discovery phase, potentially reducing time-to-market for new therapeutics.

The company's potential has been recognized by a notable pool of investors. In a recent seed investment round on October 13, 2025, Meta-flux secured €1.80M from significant players such as Gilead Sciences, Indeed, Merck, senior executives from Pfizer, and technology leaders from Google and Amazon, alongside investor Fernando Ferrer.

Business keywords: AI Biologist, Pharmaceutical Drug Development, Adaptive Experimentation, Multi-omic Data, Disease Prevention, Personalized Medicine, AI-assisted Detection, Diagnostics Platform, Computer Software Design, Data Analysis Acceleration

Services & Products

AI-driven Disease Biology Simulation
Multi-Omics Data Integration
Hypothesis-to-Insight Turnaround
Biological Data Harmonization
Simulation-Based Insights

Target Customers

Pharmaceutical Companies Biotechnology Firms Drug Development Teams R&D Departments Scientific Researchers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €1.80M 7
Gilead Sciences, Indeed +5
13 Oct 2025
Non Equity Assistance Meta Undisclosed 1
Alsessor
10 Feb 2021

Meta-flux Alternatives & Competitors

View All Alternatives
Meta-flux vs
PrognomiQ Inc
PrognomiQ Inc United States

Transform healthcare and early disease detection through the power of multi-omics data.

44 employees
Biopharma, Biotechnology
Meta-flux vs
BEYOND GENOMiX
BEYOND GENOMiX Switzerland

Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics...

4 employees
AI, Biotechnology
Meta-flux vs

The experts in AI technology for drug discovery and development.

Series C
182 employees
AI, Analytics

FAQ About Meta-flux

Meta-flux is an AI biologist for pharmaceutical drug development.
Meta-flux was founded in 2021.
Meta-flux is headquartered in Ireland.
Meta-flux operates in AI, Biotechnology and Health Care. Its work centres on AI Biologist, Pharmaceutical Drug Development, Adaptive Experimentation and Multi-omic Data. Its customers include Pharmaceutical Companies, Biotechnology Firms and Drug Development Teams.
Meta-flux has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Meta-flux has approximately 7 employees.
Meta-flux has completed 2 funding rounds, raising a total of $1.80M. The latest funding stage is Seed.
Meta-flux offers: AI-driven Disease Biology Simulation, Multi-Omics Data Integration, Hypothesis-to-Insight Turnaround, Biological Data Harmonization, Simulation-Based Insights.
Top alternatives and competitors to Meta-flux include PrognomiQ Inc, BEYOND GENOMiX, Partex.AI Technology, Terray Therapeutics, Mission Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Meta-flux and PrognomiQ Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Meta-flux, https://bouncewatch.com/company/meta-flux, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout